Newborn screening for Cerebrotendinous Xanthomatosis: A retrospective biomarker study using both flow-injection and UPLC-MS/MS analysis in 20,000 newbornsFrédéric M. Vaz, Hidde H. Huidekoper, Rob Barto et al.|Clinica Chimica Acta|2022Cited by 21